Genetic Testing Market Size Opportunities, Demand, Outlook and Forecasts 2022- 2030
Market Overview:
In a recent research report by Market
Research Community, the Genetic Testing Market is expected to surpass USD
2792.56 Million by the year 2030, from USD 930.34 Million in 2021.
The Genetic Testing Market Report refers to the industry that provides
genetic testing services to individuals, hospitals, and healthcare
organizations. These services help to identify genetic disorders and provide
information about a person's predisposition to certain diseases.
The Market
was valued at USD 930.34 Million in 2021 and is expected to experience a
compound annual growth rate (CAGR) of 12.99% from 2021 to 2030. This growth can
be attributed to the increasing demand for personalized medicine, the growing
prevalence of genetic disorders, and the genetic testing services by healthcare
organizations.
The Genetic
Testing Market includes products and services such as genetic testing kits,
sequencing services, and interpretation and reporting services. The market is
driven by the increasing demand for personalized medicine, the growing
prevalence of genetic disorders, and the increasing adoption of genetic testing
services by healthcare organizations.
Get Your Sample Report Here:
https://marketresearchcommunity.com/sample-request/?rid=2196
Market Segment
By Type
(Predictive & Presymptomatic Testing, Carrier Testing,
Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing,
Others)
By Technology
(Polymerase Chain Reaction (PCR), Next-generation
sequencing (NGS), Fluorescence in situ hybridization (FISH))
By Application
(Cancer Diagnosis, Genetic Disease Diagnosis,
Cardiovascular Disease Diagnosis, Others)
By Product
(Consumables, Equipment, Software, Services)
By End User
(Hospitals, Clinical Labs)
Genetic Testing Market Key Industry
Insights & Findings from the report:
·
Growing
awareness about the benefits of genetic testing, leading to an increase in
demand for genetic tests.
·
Advances
in technology leading to the development of high-throughput, cost-effective,
and reliable genetic tests.
·
Increasing
government funding and initiatives to promote genetic testing.
·
Rising
demand for non-invasive prenatal testing and cancer genetic testing.
The Genetic Testing Market Industry is expected to grow significantly in
the coming years, driven by the increasing demand for personalized medicine,
the growing prevalence of genetic disorders, and the increasing adoption of
genetic testing services by healthcare organizations.
By Geography
North America
is expected to be the dominant region in the Genetic Testing Market due to the
presence of a large number of genetic testing service providers and a high
level of healthcare expenditure in the region. The United States is the largest
market for genetic testing services in North America, with a large number of
leading companies operating in the market. The presence of advanced healthcare
infrastructure and a high level of awareness about genetic testing services are
also driving the growth of the market in the region.
Some of the
trends in the Genetic Testing Market include the increasing adoption of
next-generation sequencing, the growth of personalized medicine, and the
increasing demand for genetic testing in oncology.
Lastly, the
report includes a regional analysis and country analysis with the latest
trends, along with the major key players including- Myriad Genetics, Inc.
(Myriad Rbm Inc.), Eurofins Scientific, Thermo Fisher Scientific, Inc., Danaher
Corporation (Cepheid), Hoffmann-La Roche Ltd, Illumina, Inc.
Contact Us:
sales@marketresearchcommunity.com
Comments
Post a Comment